Indoco Remedies, 532612, INDOCO Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,030.95
29.84
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,442.79
0.68%
2.80

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

8.58
11.50
10.36

EBITDA CAGR (%)

10 Years
5 Years
3 Years

9.24
30.13
5.55

PAT CAGR (%)

10 Years
5 Years
3 Years

9.39
-
15.20

P:E (Median)

8 Years
5 Years
3 Years

29.59
24.43
24.73

P:BV (Average)

8 Years
5 Years
3 Years

3.45
3.44
3.76

EV:EBITDA (Average)

8 Years
5 Years
3 Years

15.57
15.94
13.18

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 449.05 398.64 12.65% 473.39 432.69 9.41% 422.88 407.90 3.67% 427.46 408.88 4.54%
Expenses 383.76 336.99 13.88% 400.97 344.93 16.25% 359.97 336.60 6.94% 363.29 328.41 10.62%
EBITDA 65.29 61.65 5.90% 72.42 87.76 -17.48% 62.91 71.30 -11.77% 64.17 80.47 -20.26%
EBIDTM 14.54% 15.47% 15.30% 20.28% 14.88% 17.48% 15.01% 19.68%
Other Income 2.93 0.37 691.89% 1.12 0.34 229.41% 0.41 1.13 -63.72% 0.49 0.29 68.97%
Interest 10.03 7.01 43.08% 8.10 5.25 54.29% 7.78 4.13 88.38% 8.64 3.04 184.21%
Depreciation 22.97 17.16 33.86% 21.41 15.65 36.81% 19.87 20.10 -1.14% 17.69 18.04 -1.94%
PBT 27.02 37.85 -28.61% 44.03 67.20 -34.48% 35.67 48.20 -26.00% 38.33 59.68 -35.77%
Tax 7.01 9.98 -29.76% 10.89 17.56 -37.98% 9.73 9.73 0.00% 12.96 19.31 -32.88%
PAT 20.01 27.87 -28.20% 33.14 49.64 -33.24% 25.94 38.47 -32.57% 25.37 40.37 -37.16%
PATM 4.46% 6.99% 7.00% 11.47% 6.13% 9.43% 5.94% 9.87%
EPS 2.17 3.02 -28.15% 3.59 5.38 -33.27% 2.81 4.17 -32.61% 2.75 4.38 -37.21%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 459.42 399.20 15.09% 481.73 433.04 11.24% 426.50 408.22 4.48% 428.16 409.13 4.65%
Expenses 396.52 337.16 17.61% 410.36 345.19 18.88% 365.33 336.77 8.48% 363.40 328.59 10.59%
EBITDA 62.90 62.04 1.39% 71.37 87.85 -18.76% 61.17 71.45 -14.39% 64.76 80.54 -19.59%
EBIDTM 13.69% 15.54% 14.82% 20.29% 14.34% 17.50% 15.13% 19.69%
Other Income 2.35 0.36 552.78% 4.43 0.35 1,165.71% 0.41 1.13 -63.72% 0.50 0.30 66.67%
Interest 10.07 7.01 43.65% 8.11 5.25 54.48% 7.79 4.13 88.62% 8.64 3.04 184.21%
Depreciation 24.35 17.17 41.82% 21.41 15.65 36.81% 19.88 20.10 -1.09% 17.69 18.05 -1.99%
PBT 22.63 38.22 -40.79% 46.28 67.30 -31.23% 33.91 48.35 -29.87% 38.93 59.75 -34.85%
Tax 7.07 10.07 -29.79% 11.04 17.57 -37.17% 9.73 9.78 -0.51% 13.12 19.30 -32.02%
PAT 15.56 28.15 -44.72% 35.24 49.73 -29.14% 24.18 38.57 -37.31% 25.81 40.45 -36.19%
PATM 3.39% 7.05% 7.32% 11.48% 5.67% 9.45% 6.03% 9.89%
EPS 1.77 3.05 -41.97% 3.81 5.40 -29.44% 2.65 4.19 -36.75% 2.80 4.39 -36.22%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 1,772.78 1,666.69 1,539.72 1,240.30 1,105.99 967.73 1,038.21 1,072.06 1,004.76 854.00 727.71 Net Sales Growth 7.56% 8.25% 24.14% 12.14% 14.29% -6.79% -3.16% 6.70% 17.65% 17.35% Cost Of Goods Sold 536.49 521.29 456.75 354.07 330.43 320.17 346.03 359.60 347.97 298.45 269.17 Gross Profit 1,236.29 1,145.40 1,082.97 886.24 775.57 647.56 692.18 712.46 656.79 555.55 458.55 GP Margin 69.74% 68.72% 70.34% 71.45% 70.12% 66.92% 66.67% 66.46% 65.37% 65.05% 63.01% Total Expenditure 1,507.99 1,381.85 1,213.81 1,022.67 985.01 891.03 906.73 917.40 836.83 688.80 609.86 Power & Fuel Cost - 50.61 42.78 36.89 34.75 28.49 26.62 23.12 21.72 20.39 18.26 % Of Sales - 3.04% 2.78% 2.97% 3.14% 2.94% 2.56% 2.16% 2.16% 2.39% 2.51% Employee Cost - 321.15 294.95 272.88 255.32 231.26 220.34 216.05 181.41 139.64 129.05 % Of Sales - 19.27% 19.16% 22.00% 23.09% 23.90% 21.22% 20.15% 18.06% 16.35% 17.73% Manufacturing Exp. - 195.91 184.62 130.30 114.61 106.86 101.47 96.11 84.80 52.60 39.66 % Of Sales - 11.75% 11.99% 10.51% 10.36% 11.04% 9.77% 8.96% 8.44% 6.16% 5.45% General & Admin Exp. - 122.71 107.50 98.28 128.33 110.90 109.03 116.21 102.31 90.21 83.30 % Of Sales - 7.36% 6.98% 7.92% 11.60% 11.46% 10.50% 10.84% 10.18% 10.56% 11.45% Selling & Distn. Exp. - 111.33 83.19 76.02 89.28 62.75 70.53 73.22 55.89 50.99 47.82 % Of Sales - 6.68% 5.40% 6.13% 8.07% 6.48% 6.79% 6.83% 5.56% 5.97% 6.57% Miscellaneous Exp. - 58.84 44.02 54.23 32.31 30.58 32.70 33.09 42.73 36.51 47.82 % Of Sales - 3.53% 2.86% 4.37% 2.92% 3.16% 3.15% 3.09% 4.25% 4.28% 3.11% EBITDA 264.79 284.84 325.91 217.63 120.98 76.70 131.48 154.66 167.93 165.20 117.85 EBITDA Margin 14.94% 17.09% 21.17% 17.55% 10.94% 7.93% 12.66% 14.43% 16.71% 19.34% 16.19% Other Income 4.95 2.62 6.71 9.05 4.79 6.71 8.15 6.10 4.14 1.74 3.96 Interest 34.55 25.27 17.43 22.22 26.25 21.09 23.51 6.16 12.15 10.34 18.80 Depreciation 81.94 70.60 78.95 73.12 70.81 71.56 67.71 63.27 60.63 47.11 30.91 PBT 145.05 191.59 236.23 131.35 28.71 -9.24 48.43 91.34 99.29 109.48 72.11 Tax 40.59 50.23 81.71 38.96 4.46 -6.40 7.23 13.88 17.00 26.67 14.21 Tax Rate 27.98% 26.22% 34.59% 29.66% 15.53% 69.26% 14.93% 15.20% 17.12% 24.36% 19.71% PAT 104.46 141.36 154.52 92.39 24.25 -2.84 41.20 77.46 82.29 82.81 57.90 PAT before Minority Interest 104.46 141.36 154.52 92.39 24.25 -2.84 41.20 77.46 82.29 82.81 57.90 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.89% 8.48% 10.04% 7.45% 2.19% -0.29% 3.97% 7.23% 8.19% 9.70% 7.96% PAT Growth -33.19% -8.52% 67.25% 280.99% - - -46.81% -5.87% -0.63% 43.02% EPS 11.33 15.33 16.76 10.02 2.63 -0.31 4.47 8.40 8.93 8.98 6.28

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 1,795.81 1,668.61 1,540.75 1,241.53 1,106.58 968.45 1,041.94 1,074.77 1,008.12 857.32 732.61 Net Sales Growth 8.86% 8.30% 24.10% 12.20% 14.26% -7.05% -3.05% 6.61% 17.59% 17.02% Cost Of Goods Sold 549.78 521.29 456.79 354.10 330.43 320.25 347.83 361.27 350.01 300.44 271.98 Gross Profit 1,246.03 1,147.32 1,083.97 887.42 776.15 648.19 694.11 713.49 658.12 556.87 460.63 GP Margin 69.39% 68.76% 70.35% 71.48% 70.14% 66.93% 66.62% 66.39% 65.28% 64.95% 62.88% Total Expenditure 1,535.61 1,382.57 1,214.50 1,023.20 985.74 891.80 910.37 920.27 840.17 691.81 614.44 Power & Fuel Cost - 50.61 42.78 36.89 34.75 28.49 26.62 23.12 21.72 20.39 18.26 % Of Sales - 3.03% 2.78% 2.97% 3.14% 2.94% 2.55% 2.15% 2.15% 2.38% 2.49% Employee Cost - 322.58 296.28 274.02 256.51 231.66 220.91 216.67 181.87 140.04 129.54 % Of Sales - 19.33% 19.23% 22.07% 23.18% 23.92% 21.20% 20.16% 18.04% 16.33% 17.68% Manufacturing Exp. - 195.91 184.62 130.32 114.63 107.07 101.94 96.38 85.18 52.92 40.58 % Of Sales - 11.74% 11.98% 10.50% 10.36% 11.06% 9.78% 8.97% 8.45% 6.17% 5.54% General & Admin Exp. - 121.88 106.75 97.57 127.76 110.92 110.04 116.40 102.56 90.39 83.49 % Of Sales - 7.30% 6.93% 7.86% 11.55% 11.45% 10.56% 10.83% 10.17% 10.54% 11.40% Selling & Distn. Exp. - 111.33 83.19 76.02 89.28 62.75 70.53 73.22 55.89 51.00 47.83 % Of Sales - 6.67% 5.40% 6.12% 8.07% 6.48% 6.77% 6.81% 5.54% 5.95% 6.53% Miscellaneous Exp. - 58.95 44.10 54.28 32.38 30.66 32.49 33.20 42.94 36.63 47.83 % Of Sales - 3.53% 2.86% 4.37% 2.93% 3.17% 3.12% 3.09% 4.26% 4.27% 3.11% EBITDA 260.20 286.04 326.25 218.33 120.84 76.65 131.57 154.50 167.95 165.51 118.17 EBITDA Margin 14.49% 17.14% 21.17% 17.59% 10.92% 7.91% 12.63% 14.38% 16.66% 19.31% 16.13% Other Income 7.69 2.38 3.42 9.06 4.80 6.70 8.05 5.93 4.03 1.71 3.97 Interest 34.61 25.03 14.14 22.26 26.25 21.09 23.51 6.21 12.39 10.58 18.92 Depreciation 83.33 70.61 78.96 73.13 70.82 71.57 67.71 63.28 60.66 47.09 30.90 PBT 141.75 192.79 236.57 132.00 28.57 -9.31 48.40 90.94 98.93 109.55 72.32 Tax 40.96 50.54 81.77 38.95 4.45 -6.41 7.24 13.87 16.99 26.73 14.28 Tax Rate 28.90% 26.22% 34.56% 29.51% 15.58% 68.85% 14.96% 15.25% 17.17% 24.40% 19.75% PAT 100.79 142.25 154.80 93.05 24.12 -2.90 41.16 77.06 81.94 82.81 57.98 PAT before Minority Interest 101.58 142.25 154.80 93.05 24.12 -2.90 41.16 77.06 81.94 82.81 58.03 Minority Interest 0.79 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.05 PAT Margin 5.61% 8.53% 10.05% 7.49% 2.18% -0.30% 3.95% 7.17% 8.13% 9.66% 7.91% PAT Growth -35.76% -8.11% 66.36% 285.78% - - -46.59% -5.96% -1.05% 42.83% EPS 10.93 15.43 16.79 10.09 2.62 -0.31 4.46 8.36 8.89 8.98 6.29

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 1,027.02 904.30 768.93 680.16 661.08 675.56 651.88 576.45 518.38 456.97 Share Capital 18.43 18.43 18.43 18.43 18.43 18.43 18.43 18.43 18.43 18.43 Total Reserves 1,007.93 885.87 750.50 661.73 642.65 657.13 633.45 558.02 499.95 438.54 Non-Current Liabilities 260.62 156.57 158.29 100.91 116.34 125.27 146.97 66.33 64.58 69.84 Secured Loans 143.50 95.88 96.94 96.93 128.66 123.28 132.31 34.24 9.42 7.20 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.64 3.44 6.59 Long Term Provisions 88.53 31.64 66.20 27.08 15.91 23.74 30.87 40.72 15.03 16.34 Current Liabilities 427.24 519.93 408.54 459.17 445.33 416.89 390.37 301.77 258.58 199.28 Trade Payables 126.45 135.32 115.02 166.29 170.70 149.44 164.17 131.01 118.63 69.14 Other Current Liabilities 131.88 139.46 129.33 135.35 117.02 119.32 72.07 57.30 40.88 53.88 Short Term Borrowings 119.45 103.73 117.31 105.98 113.39 109.93 118.36 86.47 73.06 56.60 Short Term Provisions 49.45 141.41 46.88 51.55 44.21 38.19 35.77 26.99 26.02 19.66 Total Liabilities 1,714.88 1,580.80 1,335.76 1,240.24 1,222.75 1,217.72 1,189.22 944.55 841.54 726.09 Net Block 661.46 554.98 569.91 589.62 467.52 488.73 439.75 373.26 339.41 325.28 Gross Block 1,406.09 1,236.03 1,177.68 1,126.60 934.50 884.96 769.49 641.58 547.28 481.41 Accumulated Depreciation 744.63 681.05 607.76 536.99 466.98 396.23 329.74 268.32 207.87 156.14 Non Current Assets 907.82 714.79 713.81 678.48 686.25 680.57 619.04 483.08 460.11 424.88 Capital Work in Progress 112.57 121.53 68.10 50.70 185.43 135.56 90.63 54.80 62.71 44.12 Non Current Investment 18.90 2.46 2.45 2.45 2.44 2.61 2.82 2.61 0.64 0.45 Long Term Loans & Adv. 112.65 25.98 63.95 26.07 21.75 33.58 66.34 48.02 57.13 54.80 Other Non Current Assets 2.25 9.83 9.39 9.64 9.11 20.09 19.51 4.39 0.21 0.25 Current Assets 807.05 866.01 621.95 561.76 536.50 537.15 570.18 461.46 381.43 301.20 Current Investments 1.00 0.00 0.00 0.00 0.00 0.00 0.00 15.68 0.00 0.00 Inventories 325.99 310.52 237.81 208.24 183.37 193.23 185.04 164.47 146.20 108.26 Sundry Debtors 350.82 297.00 233.58 209.18 194.47 207.83 215.73 187.72 153.64 137.25 Cash & Bank 12.40 19.21 14.05 37.65 36.18 11.81 62.40 12.44 15.28 13.14 Other Current Assets 116.85 34.59 11.89 9.11 122.48 124.28 107.01 81.15 66.31 42.55 Short Term Loans & Adv. 96.68 204.70 124.61 97.59 106.94 117.83 89.38 72.50 61.98 38.41 Net Current Assets 379.82 346.08 213.41 102.59 91.17 120.27 179.81 159.70 122.85 101.92 Total Assets 1,714.87 1,580.80 1,335.76 1,240.24 1,222.75 1,217.72 1,189.22 944.54 841.54 726.08

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 1,028.25 904.64 768.99 679.57 660.62 674.98 651.34 576.52 518.80 457.15 Share Capital 18.43 18.43 18.43 18.43 18.43 18.43 18.43 18.43 18.43 18.43 Total Reserves 1,009.16 886.21 750.56 661.14 642.19 656.55 632.91 558.08 500.37 438.72 Non-Current Liabilities 260.94 156.60 158.36 101.00 116.42 125.34 147.04 66.28 64.65 69.87 Secured Loans 143.50 95.88 96.94 96.93 128.66 123.28 132.31 34.24 9.42 7.20 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.64 3.44 6.59 Long Term Provisions 88.90 31.74 66.35 27.14 15.95 23.77 30.91 40.63 15.04 16.36 Current Liabilities 424.51 518.16 406.92 458.99 445.50 417.36 390.39 302.95 262.12 202.15 Trade Payables 123.46 133.29 113.23 165.60 170.72 149.55 164.03 131.31 119.86 70.66 Other Current Liabilities 132.06 139.61 129.48 135.81 117.13 119.66 72.16 57.38 40.97 53.98 Short Term Borrowings 119.45 103.73 117.31 105.98 113.39 109.93 118.36 87.23 75.38 57.96 Short Term Provisions 49.54 141.53 46.91 51.59 44.26 38.22 35.84 27.03 25.92 19.54 Total Liabilities 1,713.70 1,579.40 1,334.27 1,239.56 1,222.54 1,217.68 1,188.77 945.75 845.57 729.42 Net Block 678.25 555.10 569.94 589.74 467.65 488.86 439.89 373.64 339.80 325.43 Gross Block 1,422.93 1,236.19 1,177.74 1,126.76 934.65 885.11 769.65 641.95 547.64 481.56 Accumulated Depreciation 744.68 681.09 607.80 537.02 467.00 396.25 329.75 268.32 207.84 156.13 Non Current Assets 905.52 712.47 711.75 676.45 684.49 678.73 616.72 481.20 460.22 424.85 Capital Work in Progress 113.60 121.53 68.19 50.70 185.43 135.56 90.63 54.80 62.71 44.12 Non Current Investment 1.46 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.17 0.17 Long Term Loans & Adv. 109.96 25.99 64.01 26.16 22.01 33.92 66.46 48.15 57.31 54.88 Other Non Current Assets 2.25 9.83 9.59 9.83 9.38 20.36 19.72 4.60 0.22 0.25 Current Assets 808.18 866.92 622.53 563.10 538.05 538.96 572.05 464.55 385.36 304.56 Current Investments 1.00 0.00 0.00 0.00 0.00 0.00 0.00 15.68 0.00 0.00 Inventories 325.99 310.52 237.85 208.32 183.45 193.38 186.94 166.69 149.12 110.22 Sundry Debtors 350.94 297.25 233.82 210.14 195.84 209.51 215.68 188.83 155.38 138.13 Cash & Bank 13.35 19.77 14.34 37.93 36.26 11.90 62.59 12.63 15.40 13.39 Other Current Assets 116.91 34.59 11.90 9.11 122.51 124.17 106.85 80.72 65.46 42.83 Short Term Loans & Adv. 96.73 204.80 124.62 97.60 106.96 117.71 89.21 72.06 61.13 38.68 Net Current Assets 383.67 348.77 215.61 104.12 92.55 121.60 181.66 161.60 123.23 102.41 Total Assets 1,713.70 1,579.39 1,334.28 1,239.55 1,222.54 1,217.69 1,188.77 945.75 845.58 729.41

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 175.59 173.55 82.17 122.66 132.13 122.76 87.81 112.31 109.91 99.94 PBT 191.59 236.23 131.35 28.71 -9.24 48.43 91.34 99.29 109.48 72.11 Adjustment 120.88 87.12 109.71 99.51 89.34 97.82 64.31 78.78 64.96 50.27 Changes in Working Capital -75.49 -108.81 -139.14 -1.65 55.66 -13.59 -44.07 -38.46 -39.86 -7.84 Cash after chg. in Working capital 236.98 214.54 101.92 126.57 135.75 132.65 111.57 139.61 134.58 114.54 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -61.38 -40.99 -19.75 -3.92 -3.62 -9.89 -23.77 -27.31 -24.68 -14.60 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -205.31 -121.41 -66.70 -55.95 -103.76 -135.43 -170.54 -112.62 -88.39 -40.93 Net Fixed Assets -161.10 -111.78 -68.48 -57.37 -99.41 -160.40 -163.74 -86.39 -84.46 -40.81 Net Investments -17.44 -0.01 0.00 -0.01 0.17 0.21 15.47 -17.65 -0.19 -0.05 Others -26.77 -9.62 1.78 1.43 -4.52 24.76 -22.27 -8.58 -3.74 -0.07 Cash from Financing Activity 22.81 -44.37 -29.83 -63.95 -16.14 -38.77 132.40 0.17 -20.63 -58.23 Net Cash Inflow / Outflow -6.91 7.77 -14.35 2.76 12.23 -51.44 49.67 -0.15 0.89 0.78 Opening Cash & Equivalents 16.90 9.13 23.48 20.72 8.48 59.92 10.25 10.40 9.52 8.74 Closing Cash & Equivalent 9.99 16.90 9.13 23.48 20.72 8.48 59.92 10.25 10.40 9.52

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 178.84 173.83 82.22 122.85 132.11 122.72 88.64 113.34 109.04 98.81 PBT 192.79 236.57 132.00 28.57 -9.31 48.40 90.94 100.58 109.55 72.32 Adjustment 120.88 87.12 109.76 99.51 89.35 97.67 64.60 76.29 65.21 50.38 Changes in Working Capital -73.18 -108.79 -139.81 -1.49 55.62 -13.23 -43.25 -36.12 -41.01 -9.16 Cash after chg. in Working capital 240.49 214.91 101.94 126.60 135.66 132.83 112.29 140.75 133.75 113.53 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -61.65 -41.08 -19.72 -3.75 -3.55 -10.12 -23.65 -27.41 -24.71 -14.72 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -208.17 -121.41 -66.69 -55.93 -103.76 -135.43 -170.55 -111.96 -88.41 -40.98 Net Fixed Assets -161.10 -111.78 -68.48 -57.37 -99.41 -160.40 -163.74 -86.39 -84.46 -40.81 Net Investments -17.44 -0.01 0.00 -0.01 0.17 0.21 15.47 -17.65 -0.19 -0.05 Others -29.63 -9.62 1.79 1.45 -4.52 24.76 -22.28 -7.92 -3.76 -0.12 Cash from Financing Activity 22.80 -44.37 -29.87 -63.95 -16.14 -38.77 131.57 -1.48 -19.92 -58.98 Net Cash Inflow / Outflow -6.53 8.05 -14.34 2.97 12.22 -51.48 49.66 -0.11 0.70 -1.15 Opening Cash & Equivalents 17.47 9.42 23.76 20.80 8.58 60.06 10.40 10.47 9.77 10.92 Closing Cash & Equivalent 10.93 17.47 9.42 23.76 20.80 8.58 60.06 10.36 10.47 9.77

Financial Ratios

Consolidated /

Standalone

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 111.38 98.13 83.44 73.81 71.74 73.31 70.74 62.55 56.25 49.59 ROA 8.58% 10.60% 7.17% 1.97% -0.23% 3.42% 7.26% 9.21% 10.57% 8.18% ROE 14.64% 18.47% 12.75% 3.62% -0.43% 6.21% 12.61% 15.03% 16.98% 13.29% ROCE 17.42% 23.31% 15.59% 5.79% 1.24% 7.61% 11.84% 16.78% 20.66% 16.83% Fixed Asset Turnover 1.26 1.28 1.08 1.07 1.06 1.26 1.55 1.69 1.68 1.60 Receivable days 70.94 62.89 65.15 66.60 75.87 74.21 67.30 62.00 61.36 65.15 Inventory Days 69.70 64.99 65.63 64.62 71.02 66.28 58.30 56.43 53.67 49.55 Payable days 91.64 100.02 145.00 68.05 71.94 66.81 61.95 56.43 51.50 43.27 Cash Conversion Cycle 48.99 27.86 -14.22 63.17 74.95 73.68 63.66 62.01 63.53 71.42 Total Debt/Equity 0.31 0.27 0.34 0.38 0.45 0.42 0.43 0.24 0.18 0.20 Interest Cover 8.58 14.55 6.91 2.09 0.56 3.06 15.83 9.17 11.59 4.84

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 111.51 98.17 83.45 73.75 71.69 73.25 70.68 62.56 56.30 49.61 ROA 8.64% 10.63% 7.23% 1.96% -0.24% 3.42% 7.22% 9.15% 10.52% 8.17% ROE 14.72% 18.50% 12.85% 3.60% -0.43% 6.21% 12.55% 14.96% 16.97% 13.32% ROCE 17.48% 23.03% 15.67% 5.78% 1.23% 7.62% 11.80% 16.72% 20.63% 16.84% Fixed Asset Turnover 1.26 1.28 1.08 1.07 1.06 1.26 1.55 1.69 1.69 1.61 Receivable days 70.89 62.90 65.26 66.96 76.39 74.23 67.31 62.31 61.67 64.94 Inventory Days 69.62 64.95 65.58 64.61 71.01 66.40 58.84 57.17 54.49 49.80 Payable days 89.88 98.49 143.70 67.82 71.91 66.57 61.79 56.58 52.08 43.51 Cash Conversion Cycle 50.62 29.37 -12.86 63.74 75.49 74.06 64.37 62.91 64.09 71.24 Total Debt/Equity 0.31 0.27 0.34 0.39 0.45 0.42 0.43 0.24 0.19 0.20 Interest Cover 8.70 17.73 6.93 2.09 0.56 3.06 15.64 8.98 11.35 4.82

Top Investors:

nippon life india trustee ltd-a/c nippon india small cap fund

quant mutual fund-quant small cap fund

icici prudential smallcap fund

dsp healthcare fund

hdfc trustee company ltd a/c hdfc capital builder value fund

franklin india smaller companies fund

mangeshi investment private limited

uti healthcare fund

investor education and protection fund (iepf)

llp

Annual Reports:

News Update:

Indoco Remedies’ arm commences commercial production of Pharmaceutical Intermediates
26th Mar 2024, 09:58 AM

Warren Remedies has commenced its commercial production on March 24, 2024 from its Greenfield manufacturing facility located at Aurangabad
Read More
Indoco Remedies gets nod to purchase land in Mumbai
12th Mar 2024, 17:11 PM

The Committee of Executive Directors at its meeting held on March 12, 2024 has approved the same
Read More
Indoco Remedies’ arm starts commercial production of oral care products
2nd Mar 2024, 11:36 AM

Warren Remedies has commenced its commercial production on March 1, 2024
Read More
Indoco Remedies - Quarterly Results
23rd Jan 2024, 12:29 PM

Read More
Indoco Remedies gets EIR for Goa manufacturing facility from USFDA
18th Jan 2024, 17:11 PM

The receipt of the Establishment Inspection Report indicates a successful closure of the inspection
Read More

Indoco Remedies Ltd.

Pharmaceuticals & Drugs - Global

BSE: 532612 | NSE: INDOCO

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Indoco Remedies Ltd.

Pharmaceuticals & Drugs - Global

BSE: 532612 | NSE: INDOCO

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: